Articles by Meghan Basler

Home Health: CY 2026 Proposed Rule Prompts Stakeholder Engagement

Home Health: CY 2026 Proposed Rule Prompts Stakeholder Engagement

When the comment period for the Calendar Year 2026 Home Health Prospective Payment System and DMEPOS Competitive Bidding Program Proposed Rule closed on August 29, the Centers for…

WISeR Model Signals Changes in CMS’s Approach to Prior Authorization

WISeR Model Signals Changes in CMS’s Approach to Prior Authorization

With its June announcement of the Wasteful and Inappropriate Services Reduction (WISeR) Model, the Centers for Medicare & Medicaid Services (CMS) signaled a new willingness to apply prior…

CMS Final Inpatient Rule Boosts FY 2026 Hospital Payments by 2.6%, Ends Low-Wage Index Policy, and Expands Quality Reforms

CMS Final Inpatient Rule Boosts FY 2026 Hospital Payments by 2.6%, Ends Low-Wage Index Policy, and Expands Quality Reforms

On July 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the fiscal year (FY) 2026 Hospital Inpatient Prospective Payment Systems (IPPS) for Acute Care Hospitals…

CMS Finalizes 2.6% Payment Increase and Quality Reporting Changes in the FY 2026 Inpatient Rehabilitation Facility Final Rule

CMS Finalizes 2.6% Payment Increase and Quality Reporting Changes in the FY 2026 Inpatient Rehabilitation Facility Final Rule

On August 1, the Centers for Medicare & Medicaid Services (CMS) released the fiscal year (FY) 2026 Inpatient Rehabilitation Facility (IRF) Prospective Payment System (PPS) final rule. CMS…

CMS Proposes Payment Increase, Site-Neutral Drug Administration Policy, and Full Phase-Out of IPO List by 2029

CMS Proposes Payment Increase, Site-Neutral Drug Administration Policy, and Full Phase-Out of IPO List by 2029

On July 15th, the Centers for Medicare & Medicaid Services (CMS) issued the Hospital Outpatient Prospective Payment (OPPS) and Ambulatory Surgical Center (ASC) Payment Systems proposed rule, which…

CMS Proposes 6.4% Net Payment Cut and Broad Policy Updates in CY 2026 Home Health PPS Rule

CMS Proposes 6.4% Net Payment Cut and Broad Policy Updates in CY 2026 Home Health PPS Rule

On June 30, 2025, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year (CY) 2026 Home Health Prospective Payment System proposed rule for home health…

CMS Releases IPPS FY 2026 Proposed Rule

CMS Releases IPPS FY 2026 Proposed Rule

On April 11, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the fiscal year (FY) 2026 Hospital Inpatient Prospective Payment Systems (IPPS) for Acute Care Hospitals…

CMS Releases FY 2026 Inpatient Rehabilitation Facility Prospective Payment System proposed rule

CMS Releases FY 2026 Inpatient Rehabilitation Facility Prospective Payment System proposed rule

On April 11, the Centers for Medicare & Medicaid Services (CMS) released the fiscal year (FY) 2026 Inpatient Rehabilitation Facility (IRF) Prospective Payment System (PPS) proposed rule. CMS…

11 Years of the Two-Midnight Rule: How a Controversial Policy is Shaping Medicare and Hospital Admissions in 2024

11 Years of the Two-Midnight Rule: How a Controversial Policy is Shaping Medicare and Hospital Admissions in 2024

October 1, 2024, will mark 11 years since the Centers for Medicare & Medicaid Services (CMS) established the ‘two-midnight rule’ for inpatient admissions of Medicare beneficiaries. Contentious from…

CMS Increases IRF Payments by 3.0% and Expands Social Determinants of Health Reporting

CMS Increases IRF Payments by 3.0% and Expands Social Determinants of Health Reporting

On July 31, the Centers for Medicare & Medicaid Services (CMS) released the fiscal year (FY) 2025 Inpatient Rehabilitation Facility (IRF) Prospective Payment System (PPS) final rule. CMS…

FDA’s Final Rule on LDTs Requires Hospital Engagement

FDA’s Final Rule on LDTs Requires Hospital Engagement

In a significant regulatory shift, the U.S. Food and Drug Administration (FDA) finalized its rule on April 29 regarding the oversight of Laboratory Developed Tests (LDTs). (Find Applied…

FDA Releases Highly Anticipated Final Rule on the Regulation of LDTs as Medical Devices

FDA Releases Highly Anticipated Final Rule on the Regulation of LDTs as Medical Devices

On April 29, 2024, the Food and Drug Administration (FDA) released its highly anticipated final rule, Medical Devices; Laboratory Developed Tests. This rule is scheduled to be published…